Skip to main content

Table 1 Summary of the clinical features of the patients

From: Point-of-care lung ultrasound imaging in pediatric COVID-19

Variables studied Clinical classification
Mild
(n:18)
Moderate
(n:8)
Severe/critical
(n:8)
Total
(n:34)
Epidemiological data
 Age, months
 Median (range)
23
(0.46–192)
4
(1–132)
29
(0.3–132.16)
13
(0,3–192)
 Male sex n (%) 14 (78) 4 (50) 3 (37) 21 (62)
 Chronic medical condition n (%) 9 (50) 6 (75) 3 (37) 18 (53)
Symptoms n (%)
 Fever 18 (100) 7 (87) 7 (87) 32 (94)
 Rhinorrhea 5 (27) 4 (50) 0 9 (26)
 Cough 5 (27) 5 (62) 7 (87) 17 (50)
 Dyspnea 0 8 (100) 7 (87) 15 (44)
 Nausea/vomiting 2 (11) 0 2 (25) 4 (12)
 Respiratory failure 0 0 7 (87) 7 (20)
 Shock 0 0 5 (62) 5 (15)
 Hypoxemia 0 0 8 (100) 8 (23)
 Early cardiac failurea 0 0 2 (25) 2 (6)
 Pulmonary edema 0 0 1(12) 1 (3)
Laboratorial data
 D-Dimer (ng/mL)
 Median (range)
1251
(306–5809)
1990
(190–4127)
18,536
(1932–54,153)
2250
(190–54,153)
 C-Reactive Protein (mg/L)
 Median (range)
5.4
(0.3–130)
3
(0.5–114)
185.5
(0.3–447)
20
(0.3–447)
Intensive care support n (%)
 Mechanical ventilation 0 0 5 (62) 5 (15)
 Vasoactive drug 0 0 5 (62) 5 (15)
Imaging data n (%)
 Chest RX performed 12(66) 6 (75) 7 (87) 25 (73)
 Chest RX abnormality 0 1/6 (16) 6/7(85) 7/25 (28)
 Chest CT performed 3 (16) 3 (37) 6 (75) 12 (35)
 Chest CT abnormality 1/3 (33) 3/3 (100) 6/6 (100) 10/12 (83)
 Lung US scoreb
 Median (range)
0
(0–15)
4
(0–14)
17
(2–30)
2,5
(0–30)
  1. a Present early after hospital admission, at the time lung US was performed
  2. b p value < 0.001